Search
for

    Research

    5 / 1000+ results
      Congenital Hypotrichosis Due to Short Anagen Phase

      research Congenital hypotrichosis due to short anagen

      42 citations , September 2000 in “British Journal of Dermatology”
      This report describes two children with congenital hypotrichosis and found their short hair is due to a shortened anagen phase, with the condition resolving spontaneously during puberty.
      Short Anagen Syndrome: A Case Study

      research Short Anagen Syndrome: A Case Study

      January 2012 in “Journal of Cosmetics, Dermatological Sciences and Applications”
      This article discusses short anagen syndrome, identifying it as a condition with a shorter anagen phase in hair follicles, but reports no new clinical results.

      research Short Anagen Syndrome

      28 citations , June 2010 in “Pediatric dermatology”
      This review discusses short anagen syndrome, highlighting its symptom of abnormally short scalp hair without associated systemic diseases, and notes that hair length often improves spontaneously after puberty without treatment.
      Short Anagen Syndrome: Case Series and Literature Review

      research Short anagen syndrome: Case series and literature review

      13 citations , March 2018 in “Pediatric Dermatology”
      This review describes the clinical characteristics and confirms the diagnosis of short anagen syndrome in the largest reported series to date, comparing it to loose anagen syndrome.

    Community Join

    5 / 1000+ results

      community PP405 mechanism question - looking for discussion

       7 upvotes 5 months ago
      PP405 may promote short-term hair growth by pushing follicles into the growth phase, but concerns exist about long-term effects due to lack of rest phases. Users discuss various treatments like finasteride, minoxidil, spironolactone, alfatradiol, and investigational drugs like KX-826 and GT20029 for hair maintenance and regrowth.

      community TDM-105795 phase 2 results are in!

       27 upvotes 2 years ago
      TDM-105795 showed promising hair growth results, with higher efficacy than placebo and minimal side effects. It activates dormant hair follicle stem cells and may maintain gains without immediate loss, unlike minoxidil.

      community Who else is looking forward to full phase 2 results of PP405?

      in Chat  59 upvotes 7 months ago
      PP405 is a potential hair loss treatment showing promise, especially for men with severe balding. Some are hopeful it will be a game-changer for those who cannot tolerate finasteride or minoxidil, despite skepticism about the outcomes.

      community Realistically, how much PP405 will cost?

       33 upvotes 1 year ago
      PP405 is in phase 2 trials for hair loss, with discussions on its cost and effectiveness compared to minoxidil and finasteride. Users are skeptical about its efficacy and timeline, with hopes for market release by 2027.

    Learn

    2 / 801 results

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss